USD
GBP 
CNY 
EUR 
INR 
JPY 
MYR 
ZAR 
KRW 
THB 
Patient-centric and Safety-focused Logistical Solutions will Create New Growth Opportunities
21-Aug-2020
Global
Market Research
PB21-01-00-00-00
HC03327-GL-MT_24662
In this research deliverable, Frost & Sullivan’s analyst team offers a bold perspective on the post-pandemic growth opportunities for the global CRO market. With the increased threat of COVID-19 and world-wide lockdowns in effect, the contract research organization (CROs) market is seeing interruptions in ongoing clinical trials and delays of new trials. This research service will help participants plan their production pipeline and be well prepared to tackle the dynamic market situation and the post-COVID-19 impact. This short report covers the Global Contract Research Organization Market (CRO) insights, with forecast for the total CRO market, including drug discovery and preclinical markets, with 2019 as the base year and 2020–2024 as the forecast period. Market revenue is measured in US dollars. It presents an overview and analysis of the global clinical trials and research outsourcing (CRO) market. It provides global, post-pandemic revenue forecasts for CROs. Further, qualitative information will be provided on support services, such as central laboratory services, bioanalytics, and data management. The report identifies strong CRO opportunities, with the evolving digitized ecosystem of the clinical trials due to COVID-19. The two key market trends identified are increased adoption of hybrid clinical trials and remote patient monitoring.
Research Highlights
- Pre-/post-COVID-19 impact and growth trajectory of the CRO market
- Future market outlook and underlying trends
- Major growth opportunities
Author: Khushbu Jain
Revised State of the CRO Market Due to the Pandemic
Key Forecast Criteria
Scope and Segmentation
Total Market Revenue Forecast
Total Market Revenue Forecast—Original and Revised Forecast Comparison
Drug Discovery and Preclinical CRO Revenue Forecast
Drug Discovery and Preclinical CRO Market—Post-COVID-19 Revenue Scenario
Clinical Segment Revenue Forecast
Distribution of Disrupted Trial Sites
COVID-19 Trials by Regions and Phases
Disrupted Trials—Discussion
Revenue Forecast by Peripheral Segments
Other Forecast Trends
Policy and Regulations
Policy and Regulations (continued)
Policy and Regulations (continued)
Global CRO Market Future Outlook
Global CRO Market Future Outlook (Continued)
Growth Opportunity 1: Clinical Trials for Digital Therapeutics, 2019
Growth Opportunity 1: Clinical Trials for Digital Therapeutics, 2019 (continued)
Growth Opportunity 2: Clinical Trial IT Solutions for RPM and Telemedicine, 2019
Growth Opportunity 2: Clinical Trial IT Solutions for RPM and Telemedicine, 2019 (continued)
Growth Opportunity 3: Logistical Solutions for Direct-to-Consumer Approach, 2019
Growth Opportunity 3: Logistical Solutions for Direct-to-Consumer Approach, 2019 (continued)
About the Growth Pipeline Engine™
Next Steps
List of Exhibits
Legal Disclaimer
Speak directly with our analytics experts for tailored recommendations.
Recent related Life Sciences research
13 Jan 2025 | Global | Market Outlook
Top 6 Growth Opportunities for the Digital Health Industry, 2025
Driven by digital advancements, the healthcare industry is transforming rapidly. Current trends and challenges create constant change, and industry stakeholders must adapt to remain attractive, competitive, and unique as robust organizations. Each year, competitors must gain a fresh, comprehensive v...
17 Dec 2024 | Global | Market Research
Cybersecurity in Healthcare, United States, 2024
Healthcare is the industry most affected by cyberattacks, which have targets like hospitals, healthcare organizations, patient databases, and connected devices. These attacks not only destabilize healthcare systems but also threaten care delivery and patient safety. The global healthcare infrastruct...
12 Dec 2024 | Global | Market Outlook
Top 6 Growth Opportunities for Clinical Diagnostics, Global, 2025
Accounting for 2%-3% of total healthcare expenditure and influencing 70% of clinical decision-making, diagnostics is the silent champion supporting all stages of precision health, including risk stratification, screening, early diagnosis, prognosis, monitoring, and relapse. The discovery and trans...
05 Dec 2024 | Global | Frost Radar
Frost Radar™: Enterprise Conversational AI in Healthcare, 2024
This Frost Radar™ benchmarks the companies and their solutions that allow healthcare payers and providers to create next-generation virtual assistants. Conversational AI is primarily used to streamline patient and provider processes and interactions across the care continuum—the pre-care, at-care, a...
27 Nov 2024 | Global | Market Research
Generative AI in Payer and Provider IT Transformation, Global, 2024-2029
The healthcare payer and provider industry is gradually adopting generative artificial intelligence (Gen AI) solutions across its value chain. Almost all organizations have shown an intent to implement Gen AI-based solutions in their products or processes, with a few already embarking on this journe...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
Research Highlights
- Pre-/post-COVID-19 impact and growth trajectory of the CRO market
- Future market outlook and underlying trends
- Major growth opportunities
Author: Khushbu Jain
| Deliverable Type | Market Research |
|---|---|
| No Index | No |
| Podcast | No |
| Author | Khushbu Jain |
| Industries | Healthcare |
| WIP Number | PB21-01-00-00-00 |
| Is Prebook | No |
| GPS Codes | 9600-B1,9611-B1 |
Hybridization of Clinical Trial Designs Reviving Global CRO Market Post-pandemic, 2019–2024
$4,950.00
Special Price $3,712.50 save 25 %